Comparison 10. Sclerotherapy plus compression versus sclerotherapy alone.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
10.1 Resolution or improvement of telangiectasias	2	196	Std. Mean Difference (IV, Random, 95% CI)	0.09 [‐0.19, 0.37]
10.2 Adverse events	2		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
10.2.1 Hyperpigmentation	2	196	Risk Ratio (M‐H, Random, 95% CI)	0.93 [0.41, 2.07]
10.2.2 Matting	1	96	Risk Ratio (M‐H, Random, 95% CI)	1.84 [0.17, 19.62]
10.3 Quality of life	1		Std. Mean Difference (IV, Random, 95% CI)	Totals not selected